Home Catalyst Pharmaceutical

Catalyst Pharmaceutical

acquired
IPO Delisting
Rare Neurological and Neuromuscular Disease Therapeutics Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Catalyst is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare, debilitating neuromuscular and neurological disorders. At Catalyst, we harness cutting-edge science to find treatments that improve the lives of those suffering from rare diseases, often where no treatment options exist. We believe there is no area of medicine with as much promise and potential to profoundly impact patients' lives as the development of new orphan drugs.
Catalyst Pharmaceuticals, Inc.
Florida,United States of America
15~50 people
January 01, 2002
info@catalystpharma.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Biotechnology
Concept
# Brain Sciences # Nervous System Diseases Rare Diseases Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs